Michigan · G0472

Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in Michigan

Michigan Medicare Avg
$45.39
1% above national avg
National Medicare Avg
$44.86
All states combined
Billed Charge (MI)
$47.31
What providers submit
Est. Commercial (MI)
$96.23
National avg: $100.48
Est. Cash / Self-Pay (MI)
$47.06
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

495
Services in MI
6
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Michigan

Provider Medicare Services
Laboratory Corporation Of America $45.42 477

Michigan Pricing in Context

In Michigan, CPT code G0472 (Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s)) carries an average Medicare payment of $45.39 — 1% above the national benchmark of $44.86. 6 providers across the state submitted claims for this procedure in 2023, performing 495 total services. Individual payments in MI ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Michigan is $47.31, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Michigan sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Preventive Screening procedures, the estimated commercial insurance price in Michigan lands near $96.23, with self-pay cash prices typically around $47.06. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cost in Michigan?

The average Medicare payment for Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in Michigan is $45.39, which is 1% above the national average of $44.86. Providers in MI typically bill $47.31 for this procedure.

What does Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cost with insurance in Michigan?

With commercial insurance in Michigan, Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) costs an estimated $96.23. Without insurance, the estimated cash price is $47.06. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in Michigan?

6 providers in Michigan billed Medicare for Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) in 2023, performing 495 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) cheaper in Michigan than the national average?

No — Hepatitis C Antibody Screening, For Individual At High Risk And Other Covered Indication(s) costs 1% above the national average in Michigan. The state average Medicare payment is $45.39 compared to $44.86 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial